According to Nova one advisor, The U.S. Stethoscope market size was valued at US$ 145.32 million in 2021 and is expected to hit US$ 221.06 million by 2030, growing at a compound annual growth rate (CAGR) of 8.7% from 2022 to 2030.
According to Nova one advisor, The U.S. Stethoscope market size was valued at US$ 145.32 million in 2021 and is expected to hit US$ 221.06 million by 2030, growing at a compound annual growth rate (CAGR) of 8.7% from 2022 to 2030.
Growth Factors:
Increasing cardiovascular and respiratory diseases and the growing aging population are the major factors expected to drive the U.S. market. In addition, the adoption of technologically advanced products, such as Bluetooth integrated stethoscopes, and various government initiatives are few more factors contributing to the growth of the market. Moreover, the recent outbreak of COVID-19 has increased the demand for modern digitized stethoscopes in the country. This pandemic has also led to the implementation and use of telemedicine and telehealth platforms and wearable devices as part of current standards of care in many healthcare facilities to avoid the risk of cross-contamination. Since auscultation of the lungs is generally the first procedure to determine whether the lungs are infected with COVID-19 infection or not, therefore, it is increasing the demand for stethoscopes among the end-users, starting from physicians to hospitals or home care providers. This has triggered a sudden surge in the market growth in the U.S., creating infinite prospects for market players.
Full Report is Ready | Request Sample of This Report@ https://www.novaoneadvisor.com/report/sample/6513
Report Scope of the U.S. Stethoscope Market
| Report Coverage | Details |
| Market Size in 2021 | USD 145.32 million |
| Revenue Projection By 2030 | USD 221.06 million |
| Growth Rate | CAGR of 8.7% from 2022 to 2030 |
| Base Year | 2021 |
| Historical data | 2017 - 2020 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Technology type, sales channel, end use, state, |
| Companies Mentioned | 3M; Medline Industries Inc.; Welch Allyn (Hill-Rom Holdings, Inc.);Eko Devices Inc.; GF Health Products, Inc.; Rudolf Riester GmbH (HalmaPlc); American Diagnostics Corporation; Cardionics; Heine Optotechnik GmbH & Co. KG |
The rapidly increasing geriatric population has increased the demand for stethoscopes for the primary diagnosis of numerous chronic health ailments. As per the CDC, it has been recognized that people aged above 65 years are at a higher risk of developing severe health problems, such as heart disease, common cold and flu, asthma, chronic obstructive pulmonary disease (COPD), and other conditions. According to the U.S. Census Bureau 2019 report, there are more than 54 million older adults aged 65 and older living in the U.S. This number is estimated to double to 95 million by 2060. This factor is anticipated to be one of the high growth rendering factors for the U.S. market.
The rising prevalence of heart-related diseases and various respiratory illnesses, such as asthma, acute bronchitis, cystic fibrosis, and emphysema, is propelling the market growth in the U.S. According to the American Heart Association 2016, Heart Disease and Stroke Statistics-2019 Update, almost 121.5 million adults had some form of cardiovascular disease. Similarly, as per the CDC, 4.6% of adults were diagnosed with COPD, emphysema, or chronic bronchitis in 2019. For the primary diagnosis of cardiac dysfunction and phlegm in the respiratory tract, a stethoscope is widely used to primarily examine such conditions. Thus, an increasing number of patients suffering from cardiovascular and numerous types of respiratory diseases is majorly driving the market in the U.S.
Furthermore, an increasing number of initiatives and programs being undertaken by the government of the U.S. to improve public awareness and treatment related to chronic disorders is expected to fuel the market growth over the forecast period. For instance, a national initiative called “Million Hearts 2022” is taken to prevent 1 million heart attacks within 5 years. It is a combined initiative led by the Centers for Medicare & Medicaid Services (CMS) and the Centers for Disease Control and Prevention (CDC). Similarly, the National Heart, Lung, and Blood Institute has launched a national campaign: Learn More, Breathe Better, to raise awareness and understanding of COPD and its risk factors. Moreover, this campaign helps in the early detection and treatment in slowing the disease and improving the quality of life. Thus, rising awareness among the general population regarding the treatment and initiatives taken by the government to prevent the rate of associated disorders is likely to boost the market growth.
The growing prevalence of respiratory and cardiovascular diseases, the presence of established infrastructure, and favorable reimbursement structure are among the key factors driving the stethoscope market in the U.S. As projected by the American Heart Association, by 2035, more than 130 million adults or 45.1% of the U.S. population are estimated to suffer from some form of cardiovascular disease. In addition, according to the CDC, about 655,000 Americans die from heart disease annually, representing one in every four deaths. Thus, the incidence of cardiovascular diseases is rising in the U.S., which, in turn, is likely to boost the demand for stethoscopes in the country. Moreover, rapid technological advancements, coupled with the frequent launch of new and innovative products, are among the key factors expected to fuel the market growth during the forecast period.
Full Report is Ready |Quick Buy This Premium Report From Here: https://www.novaoneadvisor.com/report/checkout/6513
Technology Type Insights
In 2021, the traditional acoustic stethoscope segment dominated the market with a revenue share of 72.99%. A traditional acoustic stethoscope in comparison to advanced stethoscopes is comparatively inexpensive, simple to use, and widely available for use by paramedics and nurses. In developing countries where sophisticated medical imaging penetration in rural areas is limited, this stethoscope plays an important role in the diagnosis of cardiac and pulmonary disorders. Moreover, smart stethoscopes are not within the reach of all small healthcare facilities and hospitals in the Sub-Saharan African region. These factors are anticipated to boost the demand for traditional acoustic stethoscopes over the forecast period. Based on technology type, the U.S. market is segmented into electronic/digital stethoscopes, smart stethoscopes, and traditional acoustic stethoscopes.
The smart stethoscopes segment is expected to expand at the highest revenue-based CAGR of 5.9% from 2022 to 2030. High patient volume suffering from cardiac and lung disorders and incorporation of smart technologies, like AI into stethoscopes, will upsurge the espousal of smart stethoscopes over the forecast period. Moreover, continuous R&D investments to innovate and develop the latest smart stethoscopes are anticipated to boost market growth during the forecast period. For instance, Sonavi Labs, formed by Johns Hopkins University researchers, has designed an AI-powered clever, creative, and cutting-edge stethoscope. This latest stethoscope features smart noise-filtering technology that improves the sound level of chest readings.
Sales Channel Insights
In 2021, the distributors’ segment dominated the market with a revenue share of 43.23%. Hospitals and clinics, usually, have long-term contracts and tie-ups with distributors and manufacturers. Stethoscope manufacturers are adopting long-term contracts with end users as a strategy to expand their reach and strengthen their foothold in the market. This is anticipated to boost the growth of this segment over the forecast period. Based on the sales channel, the market is segmented into distributors, e-commerce, and direct purchase.
The e-commerce segment is expected to expand at the highest revenue-based CAGR of 6.8% from 2022 to 2030. Rising online and e-commerce accessibility of stethoscopes is likely to aid in the market expansion. eHealth is a fast-growing part of e-commerce. Medical product sale through online networks is rapidly increasing as it allows the end-users to compare and select suitable products based on their type, brand, price, and point of sales. Additionally, these online stores offer product warranty with product support, access to exclusive deals, and a return policy if any product does not meet the expectations of end-users. Thus, the easy availability of different stethoscopes on online platforms is expected to fuel the segment growth in the coming years.
End-use Insights
In 2021, the hospitals’ segment dominated the market with a revenue share of 42.11% and is expected to expand at the highest CAGR in terms of revenue from 2022 to 2030. This is attributed to the growing number of patient admissions in hospitals for various medical illnesses and treatments for COVID-19. In terms of the sheer volume of stethoscopes, hospitals are observed to be the largest consumer of related products and services. In addition, an increase in the number of chronic illnesses that lead to the high hospitalization rate contributes to the high demand for stethoscopes. This is projected to strengthen the segment growth in the coming years. Based on end-use, the market is segmented into hospitals, home healthcare, clinics (individual clinics), nurse practitioners, EMT/ first responders, and veterinary.
Moreover, no other medical device can have a longer life or more usefulness than a stethoscope. It is used to listen to a patient’s cardiac, respiratory, and intestinal sounds during physical examination and assessment. These devices not only simplify treatment procedures but also help provide better, faster, and accurate results. Thus, such high usage of stethoscopes in hospitals may promote segment growth over the forecast period. Additionally, the recent outbreak of the COVID-19 pandemic is anticipated to further catalyze the demand for stethoscopes in hospitals. Thus, the above-mentioned factors are expected to drive the hospitals’ end-use segment.
Some of the prominent players in the U.S. Stethoscope market include:
- 3M
- Medline Industries Inc.
- WelchAllyn (Hill-Rom Holdings, Inc.)
- Eko Devices Inc.
- GF Health Products, Inc.
- Rudolf Riester GmbH (HalmaPlc)
- American Diagnostics Corporation
- Cardionics
- Heine Optotechnik GmbH & Co. KG.
Segments Covered in the Report
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at U.S. for the period of 2017 to 2030
- By Technology Type
- Electronic/Digital Stethoscope
- Smart Stethoscope
- Traditional Acoustic Stethoscope
- By Sales Channel
- Distributors
- E-commerce
- Direct Purchase
- By End-use
- Home Healthcare
- Hospitals
- Clinics
- Nurse Practitioners
- EMT/ First Responders
- Veterinary
- By State
- California
- New York
- Texas
- Florida
- Pennsylvania
- Illinois
- Ohio
- Michigan
- Massachusetts
- New Jersey
- Rest of USA
Click Here to View Full Report Table of Contents
Key Questions Answered in U.S. Stethoscope Market Report
What will be the sales/revenue generated by U.S. Stethoscope across all regions during the forecast period?
What are the opportunities in the U.S. Stethoscope market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which application is expected to generate the highest revenue U.S. in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What is the market position of different companies operating in the U.S. market?
Full Report is Ready |Quick Buy This Premium Report From Here: https://www.novaoneadvisor.com/report/checkout/6513
You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333
About Us
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.
We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. We endeavor to give our clients latest insights on upcoming technologies, new developing markets, dynamically changing business conditions and most recent business-driven applications. These insights help our clients to take informed decisions for their business growth.
For Latest Update Follow Us:
https://www.linkedin.com/company/nova-one-advisor